Medtronic PSR TDD PMCF

NCT04714385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2024-06-04

No results posted yet for this study

Summary

The purpose of this study is to provide continuing evaluation and reporting of safety and performance of the SynchroMed II Infusion System within its intended use. Data will support post-market surveillance obligations.

Conditions

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-09
Primary Completion
2024-01-18
Completion
2024-01-18

Countries

  • Belgium
  • Czechia
  • France
  • Netherlands
  • Slovenia
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04714385 on ClinicalTrials.gov